16 septiembre 2015
A simple blood test can detect early markers of «reinvigorated» T cells and track immune responses in metastatic melanoma patients after initial treatment with the anti-PD-1 drug pembrolizumab, scientists report.
http://www.sciencedaily.com/releases/2015/09/150916145437.htm
